써모피셔사이언티픽코리아

비상장계속사업자

ThermoFisher Scientific Korea Co., Ltd.

토니아끼아리토

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

써모피셔사이언티픽코리아

Business Reg. No. 1178146910 · CEO 토니아끼아리토

I.Investment Overview

Target써모피셔사이언티픽코리아 (1178146910)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명써모피셔사이언티픽코리아
영문명ThermoFisher Scientific Korea Co., Ltd.
대표자토니아끼아리토
사업자등록번호1178146910
법인등록번호1101112846438
설립일2003.08.25

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW1,241.120211,537.720221,810.820231,89820242,053.82025
영업이익100M KRW45.82021142.92022204.82023123.72024148.92025
순이익100M KRW35.42021742022136.1202366.2202456.42025
Item20252024202320222021
자산총계1,089.5억원991.9억원801.5억원733.5억원514.5억원
부채총계655.4억원614.1억원349.9억원418.1억원273.1억원
자본총계434.1억원377.7억원451.5억원315.4억원241.4억원
매출액2,053.8억원1,898억원1,810.8억원1,537.7억원1,241.1억원
영업이익148.9억원123.7억원204.8억원142.9억원45.8억원
순이익56.4억원66.2억원136.1억원74억원35.4억원

VI.Financial Ratios

FY2025 basis

7.25%

영업이익률

2.75%

순이익률

5.18%

ROA

12.99%

ROE

150.95%

부채비율

39.85%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

써모피셔사이언티픽코리아 투심보고서 | Alpha Lenz